I'm pretty sure Cam Smith isn't a fan of them, but I think it was Johns who claimed they 64% successful, which is very hard to fathom. All comes down to the height of blokes I suppose.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market